Lower Costs, More Cures Act of 2019

10/28/2022, 1:46 AM

Lower Costs, More Cures Act of 2019

This bill establishes and modifies several requirements to address prescription drug prices under Medicare.

The bill generally

  • limits payment amounts for drugs and biologics under Medicare medical services,
  • reduces cost-sharing under the Medicare prescription drug benefit, and
  • establishes several reporting requirements for drug manufacturers with respect to drug prices.
Congress
116
Number
S - 3129
Introduced on
2019-12-19
# Amendments
0
Sponsors
+5
Cosponsors
+5

Variations and Revisions

12/19/2019
Text
PDF
XML

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Lower Costs, More Cures Act of 2019

This bill establishes and modifies several requirements to address prescription drug prices under Medicare.

The bill generally

  • limits payment amounts for drugs and biologics under Medicare medical services,
  • reduces cost-sharing under the Medicare prescription drug benefit, and
  • establishes several reporting requirements for drug manufacturers with respect to drug prices.
Alternative Names
Official Title as IntroducedA bill to provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, and for other purposes.
Policy Areas
Health
Potential Impact
Administrative law and regulatory procedures•
Advisory bodies•
Business records•
Civil actions and liability•
Competitiveness, trade promotion, trade deficits•
Congressional oversight•
Consumer affairs•
Executive agency funding and structure•
Federal officials•
Fraud offenses and financial crimes•
Government employee pay, benefits, personnel management•
Government information and archives•
Health care costs and insurance•
Health care coverage and access•
Health information and medical records•
Health personnel•
Health programs administration and funding•
Health technology, devices, supplies•
Income tax deductions•
Income tax exclusion•
Inflation and prices•
Insurance industry and regulation•
Medicaid•
Medicare•
Office of the U.S. Trade Representative•
Poverty and welfare assistance•
Prescription drugs•
Retail and wholesale trades•
Taxation•
Trade agreements and negotiations•
Women's health

Comments

Related

Member:  David Perdue
Member:  Michael B. Enzi
Bill Update Alert:  Lower Costs, More Cures Act of 2019

Recent Activity

Latest Summary1/19/2021

Lower Costs, More Cures Act of 2019

This bill establishes and modifies several requirements to address prescription drug prices under Medicare.

The bill generally

  • limits payment amounts for drugs and biologics u...
Latest Action12/19/2019
Read twice and referred to the Committee on Finance.